Novavax Inc. buy Sievi
Start price
04.10.21
/
0%
€148.30
Target price
04.10.22
-
Performance (%)
2.14%
End price
15.11.21
€151.48
Summary
This prediction ended on 15.11.21 with a price of €151.48. With a performance of 2.14%, the BUY prediction by Sievi for Novavax Inc. closed with a slight gain. This prediction was marked as speculative and is excluded from Sievi's performance statistics.Performance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Novavax Inc. | 21.830% | 21.830% | 102.726% | -91.488% |
iShares Core DAX® | -1.471% | 1.895% | 25.178% | 22.236% |
iShares Nasdaq 100 | -0.486% | 4.395% | 29.415% | 42.175% |
iShares Nikkei 225® | -2.115% | 2.450% | 20.561% | 6.454% |
iShares S&P 500 | 0.394% | 3.118% | 29.456% | 42.672% |
According to Sievi what are the pros and cons of Novavax Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Some uniques
Cons
Comments by Sievi for this prediction
In the thread Novavax Inc. diskutieren
Buy Novavax Inc.
In the thread Trading Novavax Inc.
Buy beendet
Stopped prediction by Sievi for Novavax Inc.
Novavax Inc.
Start price
Target price
Perf. (%)
€183.96
17.12.21
17.12.21
€240.00
17.12.22
17.12.22
-37.46%
10.01.22
10.01.22
Could be worthwhile Investment >10% per year
Some uniques